Norovirus recombination in ORF1/ORF2 overlap.

Norovirus (NoV) genogroups I and II (GI and GII) are now recognized as the predominant worldwide cause of outbreaks of acute gastroenteritis in humans. Three recombinant NoV GII isolates were identified and characterized, 2 of which are unrelated to any previously published recombinant NoV. Using data from the current study, published sequences, database searches, and molecular techniques, we identified 23 recombinant NoV GII and 1 recombinant NoV GI isolates. Analysis of the genetic relationships among the recombinant NoV GII isolates identified 9 independent recombinant sequences; the other 14 strains were close relatives. Two of the 9 independent recombinant NoV were closely related to other recombinants only in the polymerase region, and in a similar fashion 1 recombinant NoV was closely related to another only in the capsid region. Breakpoint analysis of recombinant NoV showed that recombination occurred in the open reading frame (ORF)1/ORF2 overlap. We provide evidence to support the theory of the role of subgenomic RNA promoters as recombination hotspots and describe a simple mechanism of how recombination might occur in NoV.

**********

Noroviruses (NoV) are divided into 5 genogroups (I-V) based on genome sequence (1). NoV genogroups I and II (GI and GII) are now recognized as the predominant worldwide cause of outbreaks of acute gastroenteritis in humans (2,3). NoV are small round virions 27-35 nm in diameter and possess a single-stranded, positive-sense RNA genome of 7.5 to 7.7 kb. The genome includes 3 overlapping open reading frames (ORFs) (4). The first ORF (ORF1) encodes a polypeptide with regions of similarity to helicase, cysteine proteinase, and RNA-dependent RNA polymerase (RdRp)-encoding regions of picornaviruses (5). ORF2 encodes a viral capsid protein (VP1), and ORF3 encodes a minor structural protein (VP2) associated with VP1 stability (6).

RNA recombination is among the major driving forces of viral evolution (reviewed in [7,8]). Recombination in viruses can greatly affect phylogenetic groupings, confuse molecular epidemiologic studies, and have major implications in viral vaccine design. A recombinant NoV can be defined as one that clusters with 2 distinct groups of NoV strains when 2 different regions (normally the capsid and polymerase) of the genome are subjected to phylogenetic analysis. The prototype Snow Mountain virus was the first reported naturally occurring recombinant NoV (9). Recently, 4 additional naturally occurring human recombinant strains have been reported: Japanese isolates Saitama U1 and the only reported GI recombinant WUG1 (10), the Thai isolate Mc37 (11), and Arg320 from Argentina (12) (Table). One recombinant strain closely related to Saitama U1 and 2 strains closely related to Mc37 have also recently been reported (13). Furthermore, outside of NoV GII but within the Caliciviridae, 2 recombinant NoV genogroup III strains associated with diarrhea in cattle (14,15) and a recombinant sapovirus (16) have also recently been reported. Analysis of these recombinants has suggested that the recombination points (or breakpoints) were near the ORF1/ORF2 overlap (9-12,14-16); however, this hypothesis has not been proven.

The aims of this study were to characterize and compare 3 recombinant NoV sequences isolated in Sydney with other published recombinant NoV and those identified through database searches and phylogenetic analysis. The genetic relationship among all identified recombinants was explored and the recombination breakpoint accurately determined. A model of NoV recombination is proposed.

Methods

Stool samples were thawed on ice from storage at -80[degrees]C and a 20% (vol/vol) stool suspension of total volume 1 mL made in water (pH 7.0). The sample was centrifuged for 1 min at 13,000 x g; the supernatant was then removed and centrifuged for a further 7 min at 13,000 x g. Viral RNA was extracted by using the QIAmp Viral RNA kit (Qiagen, Hilden, Germany) according to manufacturer's instructions. Amplification of the capsid region and a portion of the polymerase region was carried out as described previously (17). Amplification of a 507-bp region of the putative recombinant Sydney 2212/98/AU (corresponding to nucleotides 4610-5117 in Lordsdale virus, GenBank accession no. X86557) encompassing the 3' end of the polymerase region and the 5' end of ORF2 was achieved by using a nested reverse transcription-polymerase chain reaction approach. In brief, outer primers CB1 (17) and NoV2oR (5'-GTR AAC GCR TTY CCM GC-3') (R = A or G, Y = C or T, M = A or C) and inner primer pairs 2212F (5'-GTG AGC ACA GAT ATM AAM TTA-3') and 2212R (5'-AGA TGG AGY GGC GTC ATT CG-3') were used in reaction conditions, as described previously (17). The ORF1/ORF2 overlap and flanking polymerase and capsid regions of another 2 suspected recombinants, NoV/Sydney C14/02/AU and NoV/Picton/03/AU, were amplified with hep170 (5'-TCH TTY TAT GGT GAT GA-3') and GV29 (5'-CAA GAM ACW GTR AAM ACA TCA TCM CCA G-3') (W = A or T) to produce a 1,070-bp product. Products were sequenced directly on an ABI 3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA).

Recombinant NoV were identified by constructing 2 phylogenetic trees, 1 using 420 bp of the 3' end of the RNA polymerase region and the other using 550 bp of the 5' end of ORF2. Strains that did not cluster with the same group of viruses in both trees were considered putative recombinant strains. Evolutionary distances between sequences were determined by using the GCG program, DNAdist (Kimura 2-parameter method) (18). The computed distances were used to construct phylogenetic trees with Fitch (18). To gain an internal estimate of how well the data supported the phylogenetic trees, bootstrap resampling (100 datasets) of the multisequence alignments was carried out with the program Seqboot (18). The consensus tree was calculated with Consense (18). Tree branch lengths were determined by analyzing the consensus tree with Puzzle, and trees were plotted by using the program TREEVIEW (version 1.6.6) (19).

The recombination breakpoint of putative recombinant strains was determined by using 2 methods: the maximum chi-squared method (20) and Simplot (version 2.5) (21). The maximum chi-squared method is recognized as being among the most accurate when compared independently with 13 other methods (22).

Results

Recombinant NoV Strains in Australia

Sydney Cluster Strain NoV/Sydney 2212/98/AU

In 1998, a number of outbreaks of gastroenteritis occurred within daycare centers across Sydney. The etiologic agents were identified as several closely related NoV GII strains, collectively termed Sydney cluster (17). We previously reported that the closest matching strain based on sequence searches using a 298-bp fragment of the RdRp region was the Arg320/95/AR strain (17), a known recombinant NoV (12) (Table). Further sequencing a Sydney cluster isolate, Sydney 2212 (NoV/Sydney 2212/98/AU, GenBank accession no. AY588132) was carried out to determine if this strain, like Arg320, was a recombinant NoV. The collated sequence data from this study and our previous study (17) were 2,446 bp long and encompassed 819 bp of the polymerase gene and the entire capsid region. Phylogenetic analysis of Sydney 2212 placed the polymerase region within the GII.4 cluster (based on the clustering system of Vinje et al., 2004 [23]), which includes Lordsdale virus, but the capsid region grouped within the GII.3 cluster, which includes the prototype Mexico virus and New Orleans/279 (GenBank accession no. AF414412). Collectively these data demonstrate that Sydney 2212 is also a recombinant GII NoV.

NoV/Sydney C14/02/AU

During February 2002, an outbreak of gastroenteritis occurred at a children's hospital in Sydney; it affected 21 children and staff. Phylogenetic analysis of the NoV strain (NoV/Sydney C14/02/AU, GenBank accession no. AY845056) responsible for the outbreak showed that the capsid clustered in the NoV GII.3 group, which includes prototype NoV strains Mexico and Toronto (Table, Figure 1). The polymerase clustered separately, but it was more closely related to the Melksham (GII.2) virus prototype than Mexico and Toronto viruses. The distinct segregation into 2 different phylogenetic positions strongly suggested that this virus was a recombinant NoV.

[FIGURE 1 OMITTED]

NoV/Picton/03/AU

In July 2003, an outbreak of vomiting and diarrhea affecting 71 patients and staff members occurred at an eldercare facility in New South Wales, Australia. The etiologic agent was a NoV GII strain designated NoV/Picton/03/AU (GenBank accession no. AY919139). Phylogenetic analysis of 550 bp of capsid sequence indicated that this strain clustered in the NoV GII.1 group, which includes the Hawaii prototype strain (Table, Figure 1). However, the polymerase did not cluster with Hawaii virus but with the second recombinant that we identified, namely NoV/Sydney C14/02/AU, and these isolates do not group with any known genotype in the polymerase region. Furthermore, although the capsid region demonstrated 94% sequence identity to Hawaii virus, the polymerase region was unrelated, showing only 85% nucleotide sequence identity. These results indicate that Picton/03/AU was also a recombinant NoV.

Identification and Genetic Relationships

Systematic searches of the GenBank and EMBL databases and phylogenetic analysis identified a number of recombinants (Table). In GII, 9 independent recombinant NoV were identified. Two are published here, 4 were published previously (9-12), and 3 are unpublished. While 3 of the 9 recombinants were unique, 6 had 1-5 close relatives with >96% sequence identity in both polymerase and capsid regions. Sydney 2212/98/AU was closely related to the recombinant Arg320 in both polymerase and capsid regions (Table), with 97% and 96% nucleotide identity, respectively. The second recombinant we identified, Sydney C14/02/AU, was closely related to a number of strains of diverse geographic location, including Oberhausen 455/01/DE, 2 other German strains Bad Berleburg 477/01/DE and Herzberg 385/01/DE, the US isolate Paris Island/03/USA, and the Japanese isolate OS120458/01/JP (Table). The third recombinant NoV identified in the present study, Picton/03/AU, had 1 close relative identified by database searches, Gourdon78/ 00/FR. Four recombinants were identified that demonstrated >98% identity to the previously published recombinant, Saitama U1 (10), across both the polymerase and capsid regions: Honolulu314/94/US, Schwerin003/00/ DE, Gifu'96/96/JP, and 9912-02F/99/JP. The Thai NoV recombinant Mc37/03/TH (11) had 2 close relatives from Vietnam, while the French recombinant Vannes L23/99/FR was closely related to an isolate from the United States, Tiffin/99/USA. Four additional NoV GII isolates have been reported as recombinants; however, we could not confirm these reports because the polymerase sequence data were not available. These isolates include Seacroft/90/UK (24), Wortley/1990/UK (24), Stepping Hill/01/UK (25), and Harrow/01/UK (25).

For NoV genogroup I, the aforementioned WUG1 (10) was identified as a recombinant (Table), and 2 other strains (NLV/BS5/98/DE, AF093797 and NoV/Saitama KU80GI/99/JP, AB058541) could not be ruled out as recombinants because their polymerase sequences did not cluster with any other strains. Thus, 24 recombinant NoV strains are known to exist: 3 new recombinants identified in the current study, 8 previously published (9-12), and 13 either newly identified or confirmed through database searches and phylogenetic analysis.

Relationships between Regions of Recombinant NoV GII

To determine if genomic regions of the 9 representative recombinant NoV GII sequences (Table) were related to each other, phylogenetic (Figure 1) and pairwise sequence analyses (data not shown) were performed separately for the capsid region and the polymerase regions. Close relationships were found between sections of the identified recombinants (underlined in Table). The 2 Australian recombinants Sydney C14 and Picton were related to each other only in the polymerase region, with 96% nucleotide identity across a 420-bp fragment. However, their capsid regions were unrelated, showing only 73% nucleotide identity. In a similar fashion, the capsid region of Sydney 2212 was 98% identical to the capsid region of Sydney C14, while the polymerase region of Sydney 2212 shared only 85% identity with that of Sydney C14. The Japanese isolate Saitama U1 and the Thai strain Mc37 were related to each other only in the polymerase region, with 97% nucleotide identity across an 819-bp fragment, whereas alignments of their capsid regions demonstrated only 73% nucleotide identity.

Recombination in the ORF1/ORF2 Overlap

By using the maximum chi-squared method (20), the recombination site was placed either immediately upstream (6/9 recombinants) or downstream (3/9 recombinants) of the 20-bp ORF1/ORF2 overlap in genogroup II strains (p<0.0003) (Table), and similar results were obtained by using Simplot (Figure 2). Recombination within the ORF1/ORF2 overlap cannot be specifically identified because this region is 100% conserved across all NoV GII sequences. Only 1 recombinant genogroup I strain has been identified, the Japanese isolate WUGI (10). The maximum chi-squared method placed the recombination point within the 17-bp ORF1/ORF2 overlap of this genogroup I isolate (p<0.0001) (Table).

[FIGURE 2 OMITTED]

Discussion

We identified 3 recombinant NoV GII isolates responsible for outbreaks of acute gastroenteritis in New South Wales, Australia. Phylogenetic analysis of polymerase and capsid sequences of these and other recombinant NoV GII isolates showed 9 recombinant NoV GII sequences. All other recombinant NoV GII were close relatives of these (Table). The 3 NoV GII recombinant sequences identified in this study are constructed from only 2 polymerase sequences and 2 capsid sequences. They share either capsid or polymerase sequences, which suggests that the regions were derived from a pool of circulating viruses. The close geographic relationship of recombinants that share sequences in only 1 part of their genome may indicate the source location of the recombination event. In addition to the above example, this phenomenon is seen with 2 isolates from Vietnam, Vietnam 026 and Vietnam 0703, that share polymerase sequence with another Vietnamese isolate 9912-02F (Table) (13). However, the global distribution of recombinants such as Sydney C14, found in Australia, the United States, Germany, and Japan, is evidence against this hypothesis and indicates a much higher prevalence of recombinant strains in relation to other strains than was previously considered.

The putative crossover point was identified on either side of the overlap in 9 recombinant NoV GII (Table). Recombination within the overlap cannot be identified because it is 100% conserved across all NoV GII sequences and masks the breakpoint. This fact and the identification of the breakpoint at position 5359 in the recombinant NoV GI strongly suggest that recombination takes place within the reading frame overlap in NoV. The reading frame overlap and 6-7 bp of downstream sequence are closely related to sequence found at the start of the genome. In NoV GII are 28 bp that are highly conserved at both the 5' end of ORF1 and around the ORF1/ORF2 overlap, with a consensus sequence of 5'-GTG AAT GAA GAT GGC GTC KAR YGA CGC Y-3' (bases involved in the formation of stem loop structures are underlined). In NoV GI, 27 bp are highly conserved at the 5' end of the genome and the ORF1/ORF2 overlap region with a consensus sequence of 5'-GYR AAT GAT GAT GGC GTC KAA RGA CGY-3'. The 2 highly conserved regions for NoV GI and GII contain 2 in-frame and 3 in-frame start codons, respectively. The duplication of a conserved sequence at the start of ORF1 and ORF2 is characteristic of caliciviruses and is seen in all 4 genera, NoV, sapovirus, lagovirus, and vesivirus (5,26-28). This repetition at the 5' end of the 2 major ORFs led us to consider the role of ORF1/ORF2 as a negative-strand subgenomic RNA promoter site. Indeed, a subgenomic RNA promoter is required for subgenomic RNA synthesis and is often found in close proximity to the 5' end of subgenomic RNA species (29). The presence of a subgenomic RNA has not been proven in NoV, but it is highly likely based on transcription in related viruses (26,27,30). For example, subgenomic RNA species have been identified, with 5' ORF2 sequences, in 2 caliciviruses, namely, feline calicivirus (26,27) and rabbit hemorrhagic disease virus (RHDV) (30). The recent and first report of a calicivirus subgenomic RNA promoter in RHDV at the 5' end of ORF2 provides evidence to support this hypothesis (30). Additionally, RNA promoter regions often have stern loop structures (reviewed in [31]); such structures have been identified within the repeated sequences found at the start of ORF1 and ORF2 of NoV (see sequences above) (28). Taken together, strong evidence exists that the conserved 27/28-bp sequence found at the 5' end of the NoV genome and ORF2 is part of an RNA promoter sequence.

The primary mechanism involved in recombination in RNA viruses is the copy-choice model (32). In this model homologous recombination is driven by the viral encoded RdRp when pausing occurs during the transcription of a region of secondary structure. The polymerase then loses processivity and switches between RNA templates (reviewed in [7,8]). A number of models of subgenomic synthesis have been proposed, but the most widely recognized is the internal initiation mechanism (33). Here the replicase initiates positive-strand subgenomic transcription internally on a negative-strand copy of genomic RNA (29). Using these 2 well-supported models, we propose a simple mechanism for recombination in NoV (Figure 3). Replication and internal subgenomic RNA synthesis generate 2 positive RNA species. These templates direct RNA synthesis that leads to the generation of both a full-length negative genome and a negative subgenomic RNA species, in the second round of replication. The negative subgenomic RNA is the key player in our proposed model, and such species have been identified in viruses that produce subgenomic RNA (34). We propose that recombination occurs when the enzyme initiates positive-strand synthesis at the 3' end of the full-length negative strand, loses processivity at the stem loop of the ORF1/ORF2 overlap, then hops across (template switching) to an available negative subgenomic RNA species generated by a co-infecting virus (Figure 3). Alternatively, the RdRp could also template switch directly from 1 genomic RNA to another genomic RNA in the highly conserved ORF1/ORF2 overlap. The net result of both possibilities is a recombinant virus that has acquired new ORF2 and ORF3 sequences.

[FIGURE 3 OMITTED]

The decline in the prevalence of previously dominant strains, such as US-95/96 in the United States and Australia (3,17), suggests immunity in the community might be an important factor in reducing further spread of NoV. Recombination offers NoV an attractive mechanism for immune evasion. Subgenomic RNA promoters have been proposed to be recombination hotspots (35,36). In this study we have presented data to support this hypothesis, and we have described a simple mechanism of how recombination might occur in NoV.

Table. Norovirus (NoV) recombinant strains and their close relatives

                                Sequence              Parental
                                 length       strain ([double dagger])
Prototype No V
recombinant strain         RdRp                  RdRp
(ref.) *                 ([dagger])  Capsid   ([dagger])      Capsid

Arg320/1995/AR (12)         872       1647     Lordsdale        New
                                                            Orleans/279

Sydney C14/02/AU            420       550       Hawaii        Mexico
(this study)

Picton/2003/AU              420       550       Pont de      Richmond
(this study)                                    Roide
                                               AY682549

Saitama U1/02/JP (10)      1527       1666     Lordsdale      Hawaii
Mc37/03/TH (11)            1527       1647     Lordsdale        New
                                                            Orleans/306
Snow Mountain 1/            420       1629      Hawaii       Melksham
76/US (9)

E3/1997/Crete (unpub.)      872       564      Lordsdale     Melksham
VannesL23/1999/FR           815       576         MOH        Richmond
(unpub.)

S63/1999/FR (unpub.)        872       576      Melksham         MOH

WUGI/02/JP                 3370       1620     Southamp-        BS5
AB081723 (10)                                    ton/        AF093797
                                               91 L07418
                             Genotype of
                             recombinant
                             ([section])
Prototype No V
recombinant strain          RdRp               Breakpoint
(ref.) *                 ([dagger])  Capsid   ([paragraph])

Arg320/1995/AR (12)        novel     GII.3        4981

Sydney C14/02/AU           novel     GII.3        5108
(this study)

Picton/2003/AU             novel     GII.1        5039
(this study)

Saitama U1/02/JP (10)      GII.4     GII.12       5038

Mc37/03/TH (11)            GII.4     GII.10       5108

Snow Mountain 1/           novel     GII.2        4981
76/US (9)

E3/1997/Crete (unpub.)     GII.4     GII.2        5068

VannesL23/1999/FR          GII.5     GII.1/       5039
(unpub.)                             GII.12

S63/1999/FR (unpub.)       GII.2     GII.5        5117

WUGI/02/JP                 GI.4       GI.2        5359
AB081723 (10)

                               Related strains (>96%)
Prototype No V
recombinant strain             Isolate      Accession
(ref.) *                        name       no. (ref.)

Arg320/1995/AR (12)            Sydney       AY588132
                                2212       (this study)

Sydney C14/02/AU                 Bad        AF409067
(this study)                  Berleberg
                              Herzberg      AF539439
                             Oberhausen     AF539440
                                 455
                             Paris Island   AY652979
                              OS120458      AB071035

Picton/2003/AU               Gourdon 78     AY580335
(this study)

Saitama U1/02/JP (10)         Honolulu      AF414420
                               gifu 96      AB045603
                              Schwerin      AF397905
                              9912-02F      AB044366
                                              (13)
Mc37/03/TH (11)                Vietnam      AF504671
                                 026          (13)
                               Vietnam      AY237442
                                 703          (13)

Snow Mountain 1/             None found        NA
76/US (9)

E3/1997/Crete (unpub.)       None found        NA

VannesL23/1999/FR              Tiffin       AY502010
(unpub.)

S63/1999/FR (unpub.)         None found

WUGI/02/JP                   None found
AB081723 (10)

* All strains belong to genogroup II except for WUGI/02/JP, which
belongs to genogroup I.

([dagger]) RdRp, RNA-dependent RNA polymerase.

([double dagger]) Strain used to determine breakpoint, closest
matching strain in the database where enough sequence data were
available for analysis. GenBank accession nos. are in Figure 1
unless stated.

([section]) For NoV GI (strain WUGI/02/JP), the classification
system of Katayama et al. (10) was used, for GII (all other strains),
the classification system of Vinje et al. (23) was used. Closely
related sequences are underlined.

([paragraph]) Breakpoint determined by using the method of Smith (20)
relative to Lordsdale nucleotide position for NoV GII (open reading
frame [ORF]1/ORF2 overlap 5085-5104) and Norwalk for NoV GI (ORF1/ORF2
overlap 5358-5374). p value <0.0001.

Acknowledgments

We are grateful to Christopher McIver for his help with this project.

R.A.B. is supported by an Australian Postgraduate Award. G.S.H. received a PhD scholarship from Japanese Monbusho.

References

(1.) Koopmans MPG, von Bonsdorrf CH, Vinje J, DeMedici D, Monroe SS. Foodborne enteric viruses. FEMS Microbiol Rev. 2002;26:187-205.

(2.) Fankhauser RL, Monroe SS, Noel JS, Humphrey CD, Bresee JS, Parashar UD, et al. Epidemiological and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis. 2002; 186:1-7.

(3.) Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass R]. Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J Infect Dis. 1999;179:1334-44.

(4.) Atmar RL, Estes MK. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev. 200 l;14:15-37.

(5.) Green KY, Chanock RM, Kapikan AZ. Human calicivirus. In: Knipe DM, Howley PM, editors. Fields virology. Volume 1. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 841-74.

(6.) Bertolotti-Ciarlet A, White LJ, Chen R, Prasad BV, Estes MK. Structural requirements for the assembly of Norwalk virus-like particles. J Virol. 2002;76:4044-55.

(7.) Worobey M, Holmes EC. Evolutionary aspects of recombination in RNA viruses. J Gen Virol. 1999;80:2535-43.

(8.) Lai MMC. RNA recombination in animal and plant viruses. Microbiol Rev. 1992;56:61-79.

(9.) Hardy ME, Kramer SE, Treanor JJ, Estes MK. Human calicivirus genogroup II capsid sequence diversity revealed by analyses of the prototype Snow Mountain agent. Arch Virol. 1997;142:1469-79.

(10.) Katayama K, Shirato-Horikoshi H, Kojima S, Kageyama T, Oka T, Hoshino FB, et al. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology. 2002;299:225-39.

(11.) Hansman GS, Katayama K, Peerakome N, Khamrin P, Tonusin S, Okitsu S, et al. Genetic diversity of norovirus and sapovirus in hospitalized infants with sporadic cases of acute gastroenteritis in Thailand. J Clin Microbiol. 2004;42:1305-7.

(12.) Jiang X, Espul C, Zhong WM, Cuello H, Matson DO. Characterization of a novel human calicivirus that may be a naturally occurring recombinant. Arch Virol. 1999;144:2377-87.

(13.) Hansman GS, Doan LTP, Kguyen TA, Okitsu S, Katayama K, Ogawa S, et al. Detection of norovirus and sapovirus infection among children with gastroenteritis in Ho Chi Minh City, Vietnam. Arch Virol. 2004;149:1673-88.

(14.) Han MG, Smiley JR, Thomas C, Saif LJ. Genetic recombination between two genotypes of genogroup III bovine noroviruses (BoNVs) and capsid sequence diversity among BoNVs and Nebraska-like bovine enteric caliciviruses. J Clin Microbiol. 2004;42:5214-24.

(15.) Oliver SL, Brown DW, Green J, Bridger JC. A chimeric bovine enteric calicivirus: evidence for genomic recombination in genogroup III of the Norovirus genus of the Caliciviridae. Virology. 2004;326:231-9.

(16.) Katayama K, Miyoshi T, Uchino K, Oka T, Tanaka T, Naokazu T, et al. Novel recombinant sapovirus. Emerg Infect Dis. 2004; 10:1874-6.

(17.) White PA, Hansman GS, Li A, Dable J, Isaacs M, Ferson M, et al. Norwalk-like virus 95/96-US strain is a major cause of gastroenteritis outbreaks in Australia. J Med Virol. 2002;68:113-8.

(18.) Felsenstein J. PHYLIP inference package, version 3.5c. Seattle: University of Washington; 1993.

(19.) Page RDM. TREEVIEW: an application to display phylogenetic trees on personal computers. Comp Appl Biosci. 1996;12:357-8.

(20.) Smith JM. Analyzing the mosaic structure of genes. J Mol Evol. 1992;34:126-9.

(21.) Lole K, Bollinger R, Paranjape R, Gadkari D, Kulkami S, Novak N, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152-60.

(22.) Posada D. Evaluation of methods for detecting recombination from DNA sequences: empirical data. Mol Biol Evol. 2002;19:708-17.

(23.) Vinje J, Hamidjaja RA, Sobsey MD. Developmental and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup 1 and 11 noroviruses. J Virol Methods. 2004;116:109-17.

(24.) Vinje J, Green J, Lewis DC, Gallimore CI, Brown DW, Koopmans MP. Genetic polymorphism across regions of the three open reading frames of "Norwalk-like viruses." Arch Virol. 2000; 145:223-41.

(25.) Gallimore CI, Green J, Richards AF, Cotterill H, Curry A, Brown DW, et al. Methods for the detection and characterisation of noroviruses associated with outbreaks of gastroenteritis: outbreaks occurring in the north-west of England during two norovirus seasons. J Med Virol. 2004;73:280-8.

(26.) Meyers G, Wirblich C, Thiel HJ. Rabbit hemorrhagic disease virus-molecular cloning and nucleotide sequencing of a calicivirus genome. Virology. 1991 ; 184:664-76.

(27.) Herbert TP, Brierley I, Brown TDK. Detection of the ORF3 polypeptide of feline calicivirus in infected cells and evidence for its expression from a single, functionally bicistronic, subgenomic RNA. J Gen Virol. 1996;77:123-7.

(28.) Pletneva MA, Sosnovtsev SV, Green KY. The genome of Hawaii virus and its relationship with other members of the Caliciviridae. Virus Genes. 2001;23:5-16.

(29.) Miller WA, Dreher TW, Hall TC. Synthesis of brome mosaic virus subgenomic RNA in vitro by internal initiation on (-) sense genomic RNA. Nature. 1985;313:68-70.

(30.) Morales M, Barcena J, Ramirez MA, Boga JA, Parra F, Torres JM. Synthesis in vitro of rabbit hemorrhagic disease virus subgenomic RNA by internal initiation on (-) sense genomic RNA. J Biol Chem. 2004;279:17013-8.

(31.) Kao CC, Singh P, Ecker DJ. De novo initiation of viral RNA-dependent RNA synthesis. Virology. 2001;287:251-60.

(32.) Cooper PD, Steiner-Pryor A, Scotti PD, Delong D. On the nature of poliovirus genetic recombinants. J Gen Virol. 1974;23:41-9.

(33.) Miller WA, Koev G. Minireview: synthesis of subgenomic RNAs by positive-strand RNA virnses. Virology. 2000;273:1-8.

(34.) Ishikawa M, Janda M, Krol MA, Ahlquist P. In vivo DNA expression of functional brome mosaic virus RNA replicons in Saccharomyces cerevisiae. J Virol. 1997;71:7781-90.

(35.) Haseltine WA, Kleid DG, Panet A, Rothenberg E, Baltimore D. Ordered transcription of RNA tumor virus genomes. J Mol Biol. 1976;106:109-31.

(36.) van Marle G, Dobbe JC, Gultyaev AP, Luytjes W, Spaan WJ, Snijder EJ. Artevirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulation sequences. Proc Natl Acad Sci U S A. 1999;96:12056-61.

Rowena A. Bull, * Grant S. Hansman, ([dagger]) Leighton E. Clancy, * ([double dagger]) Mark M. Tanaka, * William D. Rawlinson, * ([double dagger]) and Peter A. White *

* University of New South Wales, Sydney, New South Wales, Australia; ([dagger]) University of Tokyo, Tokyo, Japan; and ([double dagger]) Prince of Wales Hospital, Randwick, New South Wales, Australia

Ms. Bull is a PhD student at the University of New South Wales. She is studying the replication and molecular epidemiology of norovirus.

Address for correspondence: Peter A. White, School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney 2052, New South Wales, Australia; fax: [phone]; email: [e-mail]